Halozyme Therapeutics (HALO) to Offer 5.2M Shares of Common Stock
Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced that it intends to offer up to 5,200,000 shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Jefferies & Company, Inc. is acting as the sole book runner for the offering.
Create E-mail AlertRelated Categories
Equity OfferingsStocks Mentioned
+0.03Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
